NanoViricides Inc. (NNVC) is a publicly traded Healthcare sector company. As of August 26, 2026, NNVC trades at $1.34 with a market cap of $32.42M and a P/E ratio of -2.09. NNVC moved +3.49% today. Year to date, NNVC is +6.61%; over the trailing twelve months it is -12.84%. Its 52-week range spans $0.85 to $2.23. Analyst consensus is buy with an average price target of $6.00. Rallies surfaces NNVC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks NNVC insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $1.34 |
| Market Cap | $32.42M |
| P/E Ratio | -2.09 |
| EPS | $-0.63 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.23 |
| 52-Week Low | $0.85 |
| Volume | 1.43K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-9.47M |
| Gross Margin | 0.00% |
2 analysts cover NNVC: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $6.00.